Vol. 31 (1) 2024 – 14

Serum selenium status in Egyptians patients who had Graves’ disease with and without ophthalmopathy The Egyptian Journal of Immunology Volume 31 (1), January, 2024 Pages: 133 – 142. www.Ejimmunology.org https://doi.org/10.55133/eji.310114 Ghada A. Hasanin1, Magda S....

Vol. 31 (1) 2024 – 13

The Role of urinary kidney injury molecule 1 (KIM-1) in monitoring the treatment response in Egyptian Lupus Nephritis Patients The Egyptian Journal of Immunology Volume 31 (1), January, 2024 Pages: 124 – 132. www.Ejimmunology.org https://doi.org/10.55133/eji.310113...

Vol. 31 (1) 2024 – 12

The role of urinary biomarker monocyte chemoattractant protein (MCP-1) in correlation with different histopathological classes of lupus nephritis in Egyptian patients The Egyptian Journal of Immunology Volume 31 (1), January, 2024 Pages: 116 – 123....

Vol. 31 (1) 2024 – 11

Assessment of long noncoding RNA CCAT1 using real time-polymerase chain reaction in colorectal cancer patients The Egyptian Journal of Immunology Volume 31 (1), January, 2024 Pages: 106 – 115. www.Ejimmunology.org https://doi.org/10.55133/eji.310111 Amal A. Mahmoud1,...

Vol. 31 (1) 2024 – 10

Insight on the hepatitis B virus and host immune mechanisms in the context of occult hepatitis The Egyptian Journal of Immunology Volume 31 (1), January, 2024 Pages: 87 – 105. www.Ejimmunology.org https://doi.org/10.55133/eji.310110 Manal El Said1,2, Asim M....

Vol. 31 (1) 2024 – 09

Evaluation of klotho expression on peripheral blood lymphocytes among hemodialysis patients and its possible contribution to their immuno-compromised status The Egyptian Journal of Immunology Volume 31 (1), January, 2024 Pages: 75 – 86. www.Ejimmunology.org...